microbiologynerd - novartis car-t therapy approved yesterday. basically this takes a cancer patients own t-cells, jon jones' them, and puts them back in the patient, and cancer is fucked.
the 1st target for this is child leukemia for which most other treatments have failed and the outlook is not good. 52 of the 63 patients given this therapy went into remission. FUCK. YOU. CANCER.
dusty up in this bitch.
This sounds like revolutionary treatment.
Do you have any idea how quickly it might be available for other cancers? For example, Novartis got FDA 'breakthrough therapy' status for this therapy back in July 2014, in connection with the child leukaemia (ALL) use that just got approved.
This exact same therapy (CTL019) received 'breakthrough therapy' status for my type of cancer, DLBCL, in April of this year. Will it roughly take the same amount of time for FDA approval, i.e., three years? Or is it quicker to get approved the second time around (assuming there are no snags in the clinical trials for DLBCL)?